# TIAM2

## Overview
TIAM2, or T-cell lymphoma invasion and metastasis 2, is a gene that encodes the TIAM Rac1 associated GEF 2 protein, a guanine nucleotide exchange factor (GEF) primarily involved in the activation of the small GTPase Rac1. This protein plays a pivotal role in regulating cytoskeletal dynamics, particularly at the nuclear envelope, and is essential for processes such as cell migration and mechanotransduction. The TIAM2 protein is characterized by structural domains, including a Dbl homology (DH) domain and a pleckstrin homology (PH) domain, which facilitate its interaction with cellular membranes and other proteins (Woroniuk2018STEFTIAM2mediated). The gene produces multiple splice variants, including TIAM2L and TIAM2S, with the latter lacking certain domains necessary for membrane translocation and potentially functioning in a GEF-independent manner (Charron2019Two; Chu2020TIAM2S). TIAM2 is implicated in various cancers, where its expression levels and interactions with signaling pathways contribute to tumor progression and resistance to therapies (Liang2022TIAM2).

## Structure
The TIAM2 protein, also known as TIAM Rac1 associated GEF 2, is characterized by several structural domains that are crucial for its function as a guanine nucleotide exchange factor (GEF) for Rac1. The protein contains a Dbl homology (DH) domain and a pleckstrin homology (PH) domain, which are essential for its interaction with membranes and other proteins (Woroniuk2018STEFTIAM2mediated). The C-terminal PH domain is particularly important for the perinuclear localization of TIAM2, as its deletion disrupts this localization (Woroniuk2018STEFTIAM2mediated). 

TIAM2 also includes a PH-CC-Ex region, which is involved in membrane targeting and exists as a monomer in solution, forming a folded globular domain (Terawaki2008Crystallographic). This region is crucial for the translocation of TIAM2 from the cytoplasm to the plasma membrane, facilitating Rac activation (Terawaki2008Crystallographic).

The TIAM2 gene produces multiple splice variants, including TIAM2L and TIAM2S. TIAM2S, a shorter isoform, lacks the N-terminal PH-CC-Ex domain and other regions necessary for membrane translocation, suggesting it may function in a GEF-independent manner (Charron2019Two; Chu2020TIAM2S). TIAM2S is primarily localized in the nucleus and is implicated in brain function and development (Chu2020TIAM2S).

## Function
The TIAM2 gene, also known as T-cell lymphoma invasion and metastasis 2, encodes a protein that functions as a guanine nucleotide exchange factor (GEF) primarily activating the small GTPase Rac1. In healthy human cells, TIAM2 plays a crucial role in regulating cytoskeletal dynamics, particularly at the nuclear envelope, where it is involved in the formation and stabilization of the perinuclear actin cap. This structure is essential for maintaining nuclear morphology, orientation, and mechanotransduction, which are critical for cellular processes such as directed migration and response to mechanical signals (Woroniuk2018STEFTIAM2mediated).

TIAM2 is localized at the nuclear envelope and interacts with key perinuclear proteins like Nesprin-2G and Non-muscle myosin IIB (NMMIIB), facilitating actomyosin contractility and nuclear integrity (Woroniuk2018STEFTIAM2mediated). The gene's activity is necessary for the stabilization of the actin cap, as its depletion leads to reduced perinuclear actin cables and altered nuclear properties, impacting cellular mechanosensing pathways (Woroniuk2018STEFTIAM2mediated). TIAM2's role in these processes underscores its importance in maintaining cellular structure and function, particularly in the context of cell migration and mechanotransduction (Woroniuk2018STEFTIAM2mediated).

## Clinical Significance
Alterations in the expression of the TIAM2 gene have been implicated in various cancers, including lung adenocarcinoma (LUAD), colorectal cancer, and hepatocellular carcinoma (HCC). In LUAD, high expression of TIAM2 is associated with resistance to the drug osimertinib, poor prognosis, and advanced clinical stages. TIAM2 contributes to osimertinib resistance by activating the PI3K/Akt/mTOR signaling pathway and promoting M2-like tumor-associated macrophage polarization, which affects the tumor microenvironment and immune modulation (Liang2022TIAM2).

In colorectal cancer, the short isoform TIAM2S is linked to tumorigenesis by disrupting serotonin homeostasis and creating a pro-inflammatory immune microenvironment. This environment is characterized by increased levels of pro-inflammatory cytokines and tumor-infiltrating lymphocytes, which facilitate tumor development (Chan2020TIAM2S).

In HCC, TIAM2S overexpression enhances cell proliferation, invasion, and epithelial-to-mesenchymal transition, contributing to cancer progression. TIAM2S is frequently overexpressed in HCC samples, suggesting its role in liver cancer pathogenesis (Chen2011Expression). These findings highlight the clinical significance of TIAM2 and its isoforms in cancer progression and resistance to therapy.

## Interactions
TIAM2, a guanine nucleotide exchange factor (GEF), primarily interacts with the small GTPase Rac1, facilitating its activation and playing a crucial role in cell migration and cytoskeletal dynamics (Liang2022TIAM2). TIAM2 is involved in the trans-endocytosis of the ephrin receptor EphB2, where it acts as a GEF to activate Rac GTPase, promoting localized Rac activation and F-actin formation necessary for this process (Gaitanos2016Tiam–Rac). This interaction is essential for cell repulsion mediated by ephrin receptor signaling (Gaitanos2016Tiam–Rac).

TIAM2 also interacts with perinuclear proteins such as Nesprin-2G and Non-muscle myosin IIB (NMMIIB) at the nuclear envelope, regulating Rac1 activity and affecting the perinuclear actin cap. This interaction is important for maintaining nuclear morphology and mechanosensing pathways (Woroniuk2018STEFTIAM2mediated). In lung adenocarcinoma, TIAM2 is implicated in the PI3K/Akt/mTOR signaling pathway, contributing to osimertinib resistance and tumor-associated macrophage polarization (Liang2022TIAM2).

TIAM2S, a variant of TIAM2, does not function as a canonical GEF but may bind directly to activated Rho family GTPases or downstream scaffold proteins to trigger signaling pathways, influencing cancer metastasis and epithelial-to-mesenchymal transition (Chen2011Expression).


## References


[1. (Liang2022TIAM2) Lu Liang, Hua He, Shiyao Jiang, Yueying Liu, Jingjing Huang, Xiaoyan Sun, Yi Li, Yiqun Jiang, and Li Cong. Tiam2 contributes to osimertinib resistance, cell motility, and tumor-associated macrophage m2-like polarization in lung adenocarcinoma. International Journal of Molecular Sciences, 23(18):10415, September 2022. URL: http://dx.doi.org/10.3390/ijms231810415, doi:10.3390/ijms231810415. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms231810415)

[2. (Charron2019Two) Yves Charron, Jürgen Willert, Bettina Lipkowitz, Barica Kusecek, Bernhard G. Herrmann, and Hermann Bauer. Two isoforms of the rac-specific guanine nucleotide exchange factor tiam2 act oppositely on transmission ratio distortion by the mouse t-haplotype. PLOS Genetics, 15(2):e1007964, February 2019. URL: http://dx.doi.org/10.1371/journal.pgen.1007964, doi:10.1371/journal.pgen.1007964. This article has 22 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1371/journal.pgen.1007964)

[3. (Gaitanos2016Tiam–Rac) Thomas N. Gaitanos, Jorg Koerner, and Ruediger Klein. Tiam–rac signaling mediates trans-endocytosis of ephrin receptor ephb2 and is important for cell repulsion. Journal of Cell Biology, 214(6):735–752, September 2016. URL: http://dx.doi.org/10.1083/jcb.201512010, doi:10.1083/jcb.201512010. This article has 28 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1083/jcb.201512010)

[4. (Chan2020TIAM2S) Ya-Ling Chan, Wei-Chung Lai, Jia-Shing Chen, Joseph Ta-Chien Tseng, Pei-Chin Chuang, Jonathan Jou, Chung-Ta Lee, and H. Sunny Sun. Tiam2s mediates serotonin homeostasis and provokes a pro-inflammatory immune microenvironment permissive for colorectal tumorigenesis. Cancers, 12(7):1844, July 2020. URL: http://dx.doi.org/10.3390/cancers12071844, doi:10.3390/cancers12071844. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cancers12071844)

[5. (Woroniuk2018STEFTIAM2mediated) Anna Woroniuk, Andrew Porter, Gavin White, Daniel T. Newman, Zoi Diamantopoulou, Thomas Waring, Claire Rooney, Douglas Strathdee, Daniel J. Marston, Klaus M. Hahn, Owen J. Sansom, Tobias Zech, and Angeliki Malliri. Stef/tiam2-mediated rac1 activity at the nuclear envelope regulates the perinuclear actin cap. Nature Communications, May 2018. URL: http://dx.doi.org/10.1038/s41467-018-04404-4, doi:10.1038/s41467-018-04404-4. This article has 48 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-018-04404-4)

[6. (Terawaki2008Crystallographic) Shin-ichi Terawaki, Ken Kitano, and Toshio Hakoshima. Crystallographic characterization of the membrane-targeting domains of the rac-specific guanine nucleotide-exchange factors tiam1 and tiam2. Acta Crystallographica Section F Structural Biology and Crystallization Communications, 64(11):1039–1042, October 2008. URL: http://dx.doi.org/10.1107/s1744309108031692, doi:10.1107/s1744309108031692. This article has 2 citations.](https://doi.org/10.1107/s1744309108031692)

[7. (Chen2011Expression) Jia‐Shing Chen, Ih‐Jen Su, Yu‐Wei Leu, Kung‐Chia Young, and H. Sunny Sun. Expression of t‐cell lymphoma invasion and metastasis 2 (tiam2) promotes proliferation and invasion of liver cancer. International Journal of Cancer, 130(6):1302–1313, May 2011. URL: http://dx.doi.org/10.1002/ijc.26117, doi:10.1002/ijc.26117. This article has 44 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/ijc.26117)

[8. (Chu2020TIAM2S) Chun‐Hsien Chu, Jia‐Shing Chen, Pei‐Chin Chuang, Chia‐Hao Su, Ya‐Ling Chan, Ying‐Ju Yang, Yu‐Ting Chiang, Yu‐Ya Su, Po‐Wu Gean, and H. Sunny Sun. Tiam2s as a novel regulator for serotonin level enhances brain plasticity and locomotion behavior. The FASEB Journal, 34(2):3267–3288, January 2020. URL: http://dx.doi.org/10.1096/fj.201901323R, doi:10.1096/fj.201901323r. This article has 13 citations.](https://doi.org/10.1096/fj.201901323R)